Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Folylpolyglutamate synthase, mitochondrial is an enzyme encoded by the FPGS gene. It catalyzes the ATP-dependent addition of glutamate residues to folate and its derivatives, converting them into polyglutamated forms. This modification allows for efficient cellular retention of folates and supports their function as essential cofactors for one-carbon transfer reactions required in nucleotide biosynthesis and amino acid metabolism. The enzyme plays a central role in maintaining both cytosolic and mitochondrial pools of folylpolyglutamates, which is critical for cell proliferation and survival. It also metabolizes antifolate drugs like methotrexate into active polyglutamated forms that inhibit key enzymes involved in DNA synthesis.
Drugs such as methotrexate act as antifolates; their efficacy depends on polyglutamation by folylpolyglutamate synthase for intracellular retention and activity against folate-dependent enzymes involved in DNA synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folylpolyglutamate synthase, mitochondrial (FPGS).